Keryx Biopharmaceuticals to Hold Conference Call Tomorrow at 8:30 AM ET to Discuss Top-Line Results from Zerenex Phase 3 Short-Term Study http://finance.yahoo.com/news/Keryx-Biopharmaceuticals-to-prnews-1835500256.html?x=0&.v=1